Back
ESC Premium Access

SGLT2 inhibition in cardiology: what a cardiologist needs to know.

Session: Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
Topic: Diabetes, dysglycaemia and metabolic syndrome
Speaker: Professor N. Sattar (Glasgow, GB)
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Boehringer Ingelheim/Lilly
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
43 presentations
8 followers

2 more presentations in this session

Introduction - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.

Speaker: Professor J. Deanfield (London, GB)

Access
Like
Thumbnail

Panel discussion; SGLT2 in clinical cardiology.

Speaker: Professor S. Anker (Berlin, DE) Professor N. Sattar (Glasgow, GB) Professor J. Deanfield (London, GB) Doctor D. Fitchett (Toronto, CA)

Access
Like
Thumbnail

Access the full session

Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)

Speakers: Professor N. Sattar, Professor J. Deanfield, Professor S. Anker, Professor N. Sattar, Professor J. Deanfield...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources